SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

RedHill Biopharma Ltd. (RDHL)

RDHL RSS Feed
Add RDHL Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017, noretreat
Search This Board:
Last Post: 9/28/2016 8:21:03 PM - Followers: 46 - Board type: Free - Posts Today: 0




Market Cap: $60 M
Cash: $14.7 M
Burn-rate : $10 per Year

Shares Out: 6.3 M ( Management holds over 2.6 M shares )
Float: 4 M






Presentation September 2013
http://files.shareholder.com/downloads/AMDA-1C0OBF/2736607566x0x690006/36cdf135-d2c9-4ce8-88d4-df998ade2152/RedHill%20Biopharma%20Presentation%20September%202013.pdf




The Company’s current product pipeline includes:

 

RHB-103 - An oral thin film formulation of rizatriptan, for the treatment of acute migraine, with a U.S. NDA filed and accepted for review by the FDA and a PDUFA date of February 3, 2014.Market Size: Worldwide triptan market for the treatment of migraine exceeds $2 billion*



RHB-102 - A once-daily formulation of ondansetron, for the treatment of chemotherapy and radiotherapy-induced nausea and vomiting, planned for U.S. NDA submission during the first quarter of 2014.Market Size: Worldwide market for serotonin (5-HT3) receptor inhibitors is estimated at $900 million**



RHB-101 - A once-daily formulation of carvedilol, for the treatment of congestive heart failure and high blood pressure, planned to be submitted for a U.S. New Drug Application (NDA) and a Marketing Authorization Application (MAA) in Europe during the second half of 2014.Market Size: Worldwide target market of $500 million**



RHB-105 - A combination therapy for Helicobacter pylori infection, planned to commence a phase II/III trial in the third quarter of 2013.Market Size: U.S. market is estimated at approximately $1-1.5 billion*



RHB-104 - A combination therapy for the treatment of Crohn’s disease, with a phase III clinical study underway.Market Size: Worldwide market exceeded $3.5 billion in 2012



RHB-104 - A combination therapy for the treatment of Multiple Sclerosis (MS), with a Phase IIa proof of concept trial currently underway.Market Size: Worldwide market of over $14 billion*



RHB-104 - A combination therapy for the treatment of Rheumatoid Arthritis, with a planned Phase IIa study.Market Size: Worldwide market of over $20 billion*



RHB-106 - An encapsulated formulation for bowel preparation (laxative) ahead of colonoscopy and other GI procedures.Market Size: Worldwide market is estimated at approximately $1.4 billion*

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RDHL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
RDHL News: Report of Foreign Issuer (6-k) 09/27/2016 08:01:08 AM
RDHL News: RedHill Biopharma to Present at the BioNetwork West 2016 Partnering Summit 09/27/2016 08:00:00 AM
RDHL News: Report of Foreign Issuer (6-k) 09/21/2016 08:01:50 AM
RDHL News: RedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea 09/21/2016 08:00:26 AM
RDHL News: RedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea 09/21/2016 08:00:00 AM
PostSubject
#228  Sticky Note CEO's own summary of the company at the tykundegex 06/22/16 04:22:25 PM
#341   Volume is right, almost 94,000 shares traded today. toddski 09/28/16 08:21:03 PM
#340   Volume Always Precedes Price?! midastouch017 09/28/16 11:00:57 AM
#339   brisk volume today. new year soon. chef911 09/27/16 03:01:29 PM
#338   RedHill Biopharma to Present at the BioNetwork West midastouch017 09/27/16 08:53:22 AM
#337   nearing an attractive price ...\ noretreat 09/26/16 07:46:34 PM
#336   similar pattern lately to daily price action. noretreat 09/23/16 02:27:11 PM
#335   RedHill Biopharma Ltd – (NASDAQ:RDHL) has been assigned midastouch017 09/23/16 12:12:39 AM
#334   Thanks for KTOV reference - seems an attractive Amatuer17 09/15/16 07:52:03 AM
#333   105 seems like a lock. They killed scottsmith 09/13/16 10:43:43 PM
#332   Agree - low float - not very high Amatuer17 09/13/16 10:41:33 PM
#331   buy the dips...in a couple years there will noretreat 09/13/16 08:10:23 PM
#330   Nice new article on RDHL in SA RedHill Biopharma: Amatuer17 09/12/16 09:51:58 PM
#329   RedHill Biopharma Announces Research Collaboration with Stanford University midastouch017 09/12/16 08:26:20 AM
#328   RedHill Biopharma Announces Phase Ib/II Study with YELIVA™ midastouch017 09/08/16 08:16:06 AM
#327   Agree! Seel 09/06/16 07:38:43 PM
#326   going up...target of 24 or so in 12 months. noretreat 09/06/16 08:23:04 AM
#325   Thanks for that. I'll check it out. Seel 09/02/16 01:03:33 PM
#324   Thanks. I will look into those. noretreat 09/02/16 06:37:06 AM
#323   Well NR, it's on my possible acquisition list Seel 09/01/16 05:40:23 PM
#322   Nice presentation that will done at conf on Amatuer17 09/01/16 04:20:40 PM
#321   This company also looks like a decent acquisition noretreat 09/01/16 12:55:33 PM
#320   It will be good to have a base noretreat 09/01/16 12:30:03 PM
#319   I sold in the 16s. Expected it scottsmith 09/01/16 09:40:51 AM
#318   RedHill Biopharma to Present at the 9th Annual midastouch017 09/01/16 09:39:15 AM
#317   I met management in January at the biotech noretreat 09/01/16 08:52:24 AM
#316   this stock is heading into the 30's. noretreat 09/01/16 08:30:18 AM
#315   Great news. This company has so much potential... tykundegex 08/29/16 09:31:06 AM
#314   RedHill Biopharma Announces Approval of a European Patent midastouch017 08/29/16 08:20:21 AM
#313   FBR Capital reiterated an Outperform rating and $36.00 midastouch017 08/24/16 12:50:43 PM
#312   Yes - this mgmt team is much more Amatuer17 08/12/16 08:04:28 AM
#311   it sure is. they gave times, and expectations chef911 08/11/16 11:14:09 PM
#310   midastouch017, Thank you! That Scrapiron 08/11/16 03:18:21 PM
#309   RedHill Biopharma Provides 2016 Semi-Annual R&D Update midastouch017 08/11/16 09:04:49 AM
#308   Where is RedHill in the development of MAP Avanger 08/10/16 11:35:45 AM
#307   Ok, what i'd like to see now is chef911 08/04/16 01:48:28 PM
#306   RDHL today in TASE midastouch017 08/04/16 10:56:47 AM
#305   Day's Range 15.30 - 16.29 midastouch017 08/04/16 10:24:50 AM
#304   Huge move up here. No one wants scottsmith 08/04/16 10:19:51 AM
#303   Word continues to get out on Redhill: scottsmith 08/03/16 09:22:01 AM
#302   fair support there at 14.80 bounced. Even if chef911 08/02/16 03:12:49 PM
#301   Anyone remember if the July corporate presentation showed scottsmith 08/02/16 02:47:45 PM
#300   Rally, baby (maybe) chef911 08/02/16 02:42:22 PM
#299   See the link for the new August corporate presentation: scottsmith 08/02/16 02:22:58 PM
#298   Me two! midastouch017 08/01/16 01:39:13 PM
#297   Very very very pleased that Redhill Biopharma is advancing! chef911 08/01/16 12:45:21 PM
#296   Average Volume 3 months - 22,026 midastouch017 08/01/16 12:15:11 PM
#295   I deleted your previous post, midastouch017 08/01/16 11:05:00 AM
#294   came up a q marks, but was supposed chef911 08/01/16 11:02:26 AM
#292   Inching up continues! midastouch017 08/01/16 09:45:00 AM
#291   RedHill Biopharma Announces Last Patient Visit in Phase midastouch017 08/01/16 08:19:30 AM
PostSubject